This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A Second View: Discussing the recent label expansion of NEXLETOL/NEXLIZET (bempedoic acid).
Ticker(s): ESPRWho's the expert?
Institution: Columbia University
- Chief of vascular surgery at NewYork-Presbyterian/Columbia University Irving Medical Center.
- A vascular surgeon-scientist, Dr. Patel is highly skilled in the full range of vascular disorders that can lead to stroke, renal issues, intestinal problems, and peripheral arterial disease.
- Interest in clinical outcomes research and has served as principal investigator of several studies to evaluate open and minimally invasive repairs of complex aortic aneurysms.
- Manages 10-15 patients monthly with Paroxysmal supraventricular tachycardia (PSVT)
Interview GoalGetting the experience of a clinician in treating patients with atherosclerotic cardiovascular disease (ASCVD).
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
